Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD

Liver International

Volumn 35, Issue 4, 2015, Pages 1367-1372

  Estep, J Michael ^a   Goodman, Zachary ^a   Sharma, Haveesh ^a,b   Younossi, Elana ^a   Elarainy, Hazem ^c   Baranova, Ancha ^b   Younossi, Zobair ^a,b,c  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

FAS; MiRNA; NAFLD; NASH; Obesity

Indexed keywords

ADAMTS6 PROTEIN; ADIPOCYTOKINE; FAS ANTIGEN; INTERLEUKIN 20; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METALLOPROTEINASE; MICRORNA; UNCLASSIFIED DRUG; AUTACOID; FAS PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; INTERLEUKIN-20 RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MALE; MOLECULE; NONALCOHOLIC FATTY LIVER; OBESITY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; WHITE ADIPOSE TISSUE; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; COMPLICATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIVER; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PARACRINE SIGNALING; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ADIPOKINES; ADIPOSE TISSUE, WHITE; ADULT; ANTIGENS, CD95; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INFLAMMATION MEDIATORS; LIVER; MALE; MICRORNAS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PARACRINE COMMUNICATION; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84924537551     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12555     Document Type: Article

References (26)

1. Petta S, Amato MC, Di Marco V, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 35: 238-47.
2. Ong J, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in obese patients. Obes Surg 2005; 15: 310-5.
3. Choudhary NS, Duseja A, Kalra N, et al. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol 2012;11:478-86.
4. Musso G, Cassader M, De Michieli F, et al. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Hepatology 2012; 56: 933-42.
5. Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 27: 412-21.
6. Machado MV, Coutinho J, Carepa F, et al. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2012; 24: 1166-72.
7. Das SK, Balakrishnan V. Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease. Indian J Clin Biochem 2011; 26: 202-9.
8. Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012; 6: 149-71.
9. Estep M, Armistead D, Hossain N, et al. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010; 32: 487-97.
10. Zhang Y, Zhou B, Deng B, et al. Amyloid-β induces hepatic insulin resistance in vivo via JAK2. Diabetes 2013; 62: 1159-66.
11. Sookoian S, Castaño G, Gianotti TF, et al. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine 2008; 44: 201-6.
12. Zhang W, Niu M, Yan K, et al. Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells. Int J Biochem Cell Biol 2013; 45: 736-44.
13. Laplante M, Sabatini DM. An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009;19: R1046-52.
14. Bakan I, Laplante M. Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol 2012; 23: 226-34.
15. Lee DF, Kuo HP, Chen CT, et al. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med 2008; 22: 633-8.
16. Shaw B, Lambert S, Wong MH, et al. Individual saturated and monounsaturated fatty acids trigger distinct transcriptional networks in differentiated 3T3-L1 preadipocytes. J Nutrigenet Nutrigenomics 2013; 6: 1-15.
17. Zabolotny JM, Kim YB, Welsh LA, et al. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 2008; 283: 14230-41.
18. Ozcan U, Ozcan L, Yilmaz E, et al. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 2008; 29: 541-51.
19. Younossi ZM, Reyes MJ, Mishra A, Mehta R, Henry L. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther 2014; 39: 3-14.
20. Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab 2008; 7: 485-95.
21. Kostadinova R, Montagner A, Gouranton E, et al. GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell Biosci 2012; 2: 34.
22. Stanya KJ, Jacobi D, Liu S, et al. Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest 2013; 123: 261-71.
23. Zeng R, Han M, Luo Y, et al. Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Nephrol Dial Transplant 2011; 26: 1149-56.
24. Wu H, Wang X, Liu S, et al. Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol 2007; 86: 331-44.
25. Yan K, Deng X, Zhai X, et al. p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells. Mol Med 2012; 10: 10-8.
26. Zhao Y, Wang Y, Wang Q, et al. Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway. Mol Cell Biochem 2012; 359: 217-23.